Purpose: Endoscopic management of upper tract urothelial carcinoma (UTUC) is associated
with higher recurrences, which could be reduced by application of topical therapy. Adjuvant …

Background The carcinoma in situ (CIS) of urinary bladder is a flat, high-grade and
aggressive manifestation of urothelial cancer which carries a great risk for progression to …

PURPOSE: We evaluated the need of routine transurethral biopsies after an induction
course of intravesical bacillus Calmette-Guérin for high grade nonmuscle invasive bladder …

Background To assess the outcomes of patients with high-grade (HG) pT1 bladder cancer
(BC) treated with intravesical BCG therapy. Methods The study population consisted of 185 …

Though radical nephroureterectomy remains the gold standard treatment for high grade or
invasive disease in upper tract urothelial cancer (UTUC), kidney-sparing surgery has …

Upper urinary tract urothelial carcinomas (UTUCs) are often identified and first treated
endoscopically. After proper risk stratification, adjuvant treatment may be recommended …

Objectives: We carried out a prospective, randomized, controlled trial to investigate the
efficacy and safety of both induction and maintenance therapy with intravesical instillation of …

Purpose: Carcinoma in situ and urothelial tumors of the upper urinary tract become
problematic in cases of bilateral occurrence or solitary kidney. Perfusions with bacillus …

Since the first reported case of using adjuvant topical immunotherapy utilizing bacillus
Calmette-Guérin (BCG) was published by Herr and associates, several institutions have …

Background The management of stage T1 poorly differentiated G3 bladder cancer invading
the lamina propria continues to be debated. These tumours are associated with a high risk of …